Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Swiss Primary Sclerosing Cholangitis Cohort Study

NCT03146936 is registered in ClinicalTrials.gov with Fondazione Epatocentro Ticino as lead sponsor.

NCT NCT03146936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03146936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Swiss Primary Sclerosing Cholangitis Cohort Study
Lead sponsor
Fondazione Epatocentro Ticino
Phase
Observational
Overall status
Recruiting
Start date
February 28, 2017
Completion date
December 31, 2030
Enrollment
120 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

cholangitis, sclerosing, primary sclerosing cholangitis (psc), psc